Test Price
2,800 AED✅ Home Collection Available
LPIN1 Gene Myoglobinuria Acute Recurrent Genetic Test in UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% clinical sensitivity via ISO‑accredited NGS workflow.
- VIP Mobile Phlebotomy: Complimentary home collection (8 AM–11 PM) with temperature‑controlled cold‑chain logistics.
- Genetic Counseling: Post‑test teleconsultation with a board‑certified medical geneticist.
- Insurance Verification: Direct WhatsApp guarantee letter check at +971 54 548 8731.
- Price: 2,800 AED (all‑inclusive, no hidden fees).
Test Overview & Methodology
The LPIN1 gene NGS test detects pathogenic variants responsible for autosomal recessive recurrent myoglobinuria, a rare metabolic muscle disorder. Full gene sequencing plus CNV analysis ensures >99.9% sensitivity, outperforming traditional Sanger methods that miss large deletions or duplications.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Technology | Next‑Generation Sequencing (full gene + CNV detection) | Sanger sequencing (selected exons only) |
| Diagnostic Sensitivity | 99.9% (deep coverage) | ~85% (misses large deletions/duplications) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Accreditation | ISO 9001:2015 & DHA‑licensed | May not be UAE‑accredited |
| Sample Options | Whole blood, DNA, or FTA card | Usually fresh blood only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403): “The LPIN1 gene test is a powerful tool for confirming genetic predisposition, but it must always be interpreted alongside clinical history, family pedigree, and metabolic work‑up. A negative result does not rule out other myopathies. I strongly recommend pre‑ and post‑test genetic counseling to ensure informed decision‑making.”
Advisory: Pre‑Test Genetic Counseling Required
A mandatory genetic counseling session (in‑person or telehealth) will be scheduled before sample collection to draw a three‑generation pedigree and discuss implications of positive, negative, or uncertain results. This process adheres to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Exclusion Criteria & Emergency Red Flags
Do not proceed without approval:
- Individuals under 18 years – parental consent required per Federal Decree‑Law No. 4 of 2016.
- Pregnant women – genetic counseling mandatory before testing.
- Patients with acute rhabdomyolysis – must be stabilized first.
Seek immediate medical care if you experience:
- Dark cola‑colored urine
- Severe muscle pain or weakness
- Confusion, nausea, or fever
- Rapid heart rate with minimal exertion
Patient FAQ & Clinical Guidance
1. What does the LPIN1 gene test diagnose?
It detects pathogenic variants in the LPIN1 gene that cause autosomal recessive recurrent myoglobinuria. This condition leads to episodes of muscle breakdown, dark urine, and risk of acute kidney injury triggered by exercise, fasting, or fever.
2. How is the test performed and what sample is needed?
A small sample of whole blood, extracted DNA, or a dried blood spot on an FTA card is collected – either by our VIP mobile phlebotomist (home visit, daily 8 AM–11 PM) or at our DHA‑licensed lab. The sample undergoes full NGS sequencing and CNV analysis; results are reported in 3–4 weeks.
3. What should I do if I test positive?
A positive result confirms a genetic predisposition. Your referring physician and our genetics team will create a personalized management plan, including avoidance of known triggers (excessive exercise, prolonged fasting), emergency protocols, and regular renal monitoring. Genetic counseling for family members is also recommended.
UAE Regulatory & Data Privacy Adherence
Data Privacy: All genetic and personal data are processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
DHA Licensing: This test is performed under DHA Facility License No. 1143. Our laboratory maintains ISO 9001:2015 certification (Cert #INT/EGQ/2509DA/3139).
Home Collection Compliance: Mobile phlebotomy follows ISO‑certified cold‑chain protocols. Samples are handled exclusively by trained personnel; results are released only to the ordering physician or direct patient after identity verification.
Clinical & Logistical Metadata
| Test Name | LPIN1 Gene Myoglobinuria Acute Recurrent Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 21–28 working days (3–4 weeks) |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) with CNV detection |
| ICD-10-CM Code | M62.89 (Myopathy, unspecified) |
| LOINC Code | 74807-9 (LPIN1 gene mutation analysis) |
| DHA Facility License & Lab Address | DHA License No. 1143 • Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians